Risankizumab in Children With Crohn’s Disease (RisaKids)
Condition(s):Crohn DiseaseLast Updated:March 7, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Crohn DiseaseLast Updated:March 7, 2024Not yet recruiting
Condition(s):Acute Ischemic StrokeLast Updated:October 6, 2023Recruiting
Condition(s):Twin Pregnancy With Antenatal ProblemLast Updated:November 24, 2023Recruiting
Condition(s):Fecal IncontinenceLast Updated:December 5, 2023Enrolling by invitation
Condition(s):Luteal Phase SupportLast Updated:May 1, 2023Recruiting
Condition(s):Leukemia, Myeloid, AcuteLast Updated:October 31, 2022Recruiting
Condition(s):Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF CyclesLast Updated:August 2, 2022Active, not recruiting
Condition(s):Coronary Artery Disease; Ischemic Heart Disease; Myocardial Infarction; STEMI; StentLast Updated:October 19, 2023Completed
Condition(s):Hot Flashes; Menopause SurgicalLast Updated:April 11, 2023Not yet recruiting
Condition(s):Myocardial Injury; Vaccine Adverse Reaction; COVID-19Last Updated:May 9, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.